Emerging drugs and targets for Alzheimer's disease v. 2 Neuronal plasticity, neuronal protection and other miscellaneous strategies

Neuronal Plasticity as target; Chapter 15: Regeneration of Degenerated Brain:A Promising Therapeutic Target; Chapter 16: Promoting synaptic resilience in AD patients through PDE inhibition; Chapter 17: A new generation of non invasive NGF-based therapies for Alzheimer's disease; Chapter 18: Possible clinical applications of stem cell strategies in AD therapies; Neuronal protection as target; Chapter 19: Targeting Oxidative Mechanisms in Alzheimer Disease; Chapter 20: Davunetide (NAP) Pharmacology: Neuroprotection and tau; Chapter 21: Targeting NF- B inflammatory and pro-survival signaling in AD; Chapter 22: PPAR inAlzheimer's disease; Miscellaneous targets and strategies; Chapter 23: Serotonin 5-HT4 receptors as pharmacological targets for the treatment of Alzheimer's disease; Chapter 24: Liver X Receptors as potential therapeutic target for AD; Chapter 25: Discovery of memoquin, a multi-target-directed ligand for the treatment of Alzheimer's disease; Chapter 26: RNA interference of genes relatedto AD; Chapter 27: Medicinal plants, phytochemicals and Alzheimer's Disease.

• ISBN: 978-1-84973-064-8
• Editorial: Royal Society of Chemistry
• Encuadernacion: Cartoné
• Páginas: 326
• Fecha Publicación: 30/06/2010
• Nº Volúmenes: 1
• Idioma: Inglés